See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2023_Aeglea_BioTherapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001636282, Aeglea BioTherapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 62,258,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,220,000 |
| 3 | remainder_Assets | 5,666,000 |
| 4 | LiabilitiesCurrent | 14,656,000 |
| 5 | LiabilitiesNoncurrent | 4,004,000 |
| 6 | remainder_Liabilities | 2,179,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,531,000 |
| 9 | ResearchAndDevelopmentExpense | 58,579,000 |
| 10 | remainder_Expenses | -136,000 |
| 11 | remainder_Revenues | 2,329,000 |
| 12 | remainder_NetIncome | 830,000 |
| 13 | remainder_ComprehensiveNetIncome | -28,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 71,144,000 |
| 1 | Liabilities | 20,839,000 |
| 2 | Expenses | 86,974,000 |
| 3 | Revenues | 2,329,000 |
| 4 | StockholdersEquity | 50,305,000 |
| 5 | NetIncome | -83,815,000 |
| 6 | ComprehensiveNetIncome | -83,829,000 |
| 7 | BaseVar | 91,072,000 |
| 8 | EconomicCapitalRatio | 0.0586 |
Edgar->Model Mapping
Feature Distribution
Change over Time
